Literature DB >> 9616361

Forms and functions of CD44.

G Borland1, J A Ross, K Guy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9616361      PMCID： PMC1364171          DOI： 10.1046/j.1365-2567.1998.00431.x

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  107 in total

1.  Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and cynomolgus monkeys.

Authors:  K H Heider; J W Mulder; E Ostermann; S Susani; E Patzelt; S T Pals; G R Adolf
Journal:  Eur J Cancer       Date:  1995-12       Impact factor: 9.162

Review 2.  Erythrocyte blood group antigens: not so simple after all.

Authors:  M J Telen
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

3.  A new alternatively spliced exon between v9 and v10 provides a molecular basis for synthesis of soluble CD44.

Authors:  Q Yu; B P Toole
Journal:  J Biol Chem       Date:  1996-08-23       Impact factor: 5.157

4.  Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type.

Authors:  R van der Voort; E Manten-Horst; L Smit; E Ostermann; F van den Berg; S T Pals
Journal:  Biochem Biophys Res Commun       Date:  1995-09-05       Impact factor: 3.575

5.  Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients.

Authors:  A Yamaguchi; T Urano; T Goi; M Saito; K Takeuchi; K Hirose; G Nakagawara; H Shiku; K Furukawa
Journal:  J Clin Oncol       Date:  1996-04       Impact factor: 44.544

6.  New CD44 splice variants associated with human breast cancers.

Authors:  N Iida; L Y Bourguignon
Journal:  J Cell Physiol       Date:  1995-01       Impact factor: 6.384

7.  Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.

Authors:  J W Mulder; P M Kruyt; M Sewnath; J Oosting; C A Seldenrijk; W F Weidema; G J Offerhaus; S T Pals
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

8.  Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer.

Authors:  D C Gotley; J Fawcett; M D Walsh; J A Reeder; D L Simmons; T M Antalis
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

9.  Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation.

Authors:  J Lesley; N English; A Perschl; J Gregoroff; R Hyman
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

10.  Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain.

Authors:  E Puré; R L Camp; D Peritt; R A Panettieri; A L Lazaar; S Nayak
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307
View more
  41 in total

1.  CD44 variant exons in leukemia and lymphoma.

Authors:  Elif Akisik; Sevil Bavbek; Nejat Dalay
Journal:  Pathol Oncol Res       Date:  2002       Impact factor: 3.201

Review 2.  Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells.

Authors:  Paul L Bollyky; Ben A Falk; Rebecca P Wu; Jane H Buckner; Thomas N Wight; Gerald T Nepom
Journal:  J Leukoc Biol       Date:  2009-04-28       Impact factor: 4.962

3.  Activation and Proliferation of PD-1+ Kidney Double-Negative T Cells Is Dependent on Nonclassical MHC Proteins and IL-2.

Authors:  Mohanraj Sadasivam; Sanjeev Noel; Sul A Lee; Jing Gong; Mohamad E Allaf; Phillip Pierorazio; Hamid Rabb; Abdel Rahim A Hamad
Journal:  J Am Soc Nephrol       Date:  2019-01-08       Impact factor: 10.121

4.  HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production.

Authors:  Maria A De Francesco; Manuela Baronio; Claudio Poiesi
Journal:  J Biol Chem       Date:  2011-04-11       Impact factor: 5.157

5.  Epithelial adhesion molecules and the regulation of intestinal homeostasis during neutrophil transepithelial migration.

Authors:  Ronen Sumagin; Charles A Parkos
Journal:  Tissue Barriers       Date:  2015-04-03

Review 6.  Tackling the cancer stem cells - what challenges do they pose?

Authors:  Diwakar R Pattabiraman; Robert A Weinberg
Journal:  Nat Rev Drug Discov       Date:  2014-07       Impact factor: 84.694

7.  Serum levels of the soluble adhesion molecules in patients with malignant melanoma.

Authors:  V Yasasever; F Tas; D Duranyildiz; H Camlica; S Kurul; N Dalay
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

8.  Met receptors induce Sam68-dependent cell migration by activation of alternate extracellular signal-regulated kinase family members.

Authors:  Alessia Locatelli; Carol A Lange
Journal:  J Biol Chem       Date:  2011-04-13       Impact factor: 5.157

9.  Synthesis and shedding of hyaluronan from plasma membranes of human fibroblasts and metastatic and non-metastatic melanoma cells.

Authors:  H J Lüke; P Prehm
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

10.  Dissimilar invasive and metastatic behavior of vincristine and doxorubicin-resistant cell lines derived from a murine T cell lymphoid leukemia.

Authors:  Eloisi C Lopes; Glenda Ernst; Paula Aulicino; Silvia Vanzulli; Mariana García; Elida Alvarez; Silvia E Hajos
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.